ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis.

Source:http://linkedlifedata.com/resource/pubmed/id/17384534

Download in:

View as

General Info

PMID
17384534